Budesonide

Overview

Budesonide is a potent corticosteroid used primarily for its anti-inflammatory properties. It is commonly used in the treatment of asthma, inflammatory bowel diseases, and allergic rhinitis.

API suppliers (19)

Suppliers of Budesonide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV2 active DMF
• FARMABIOS SPA2 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• ASPEN OSS BV1 active DMF
• NEWCHEM SPA1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• ASPEN OSS BV1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• CORAL DRUGS PVT LTD1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• STERLING SPAItaly1 active DMF
• NEWCHEM SPA1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• FARMABIOS SRL

Patent & exclusivity (US)

Per the FDA Orange Book (35 approved US products), the latest listed US patent on Budesonide expires 23 Jan 2043 and exclusivity 9 Feb 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas